Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
Sanders-van Wijk S, van Empel V, Davarzani N, Maeder MT, Handschin R, Pfisterer ME, Brunner-La Rocca HP; TIME-CHF investigators. Sanders-van Wijk S, et al. Among authors: davarzani n. Eur J Heart Fail. 2015 Oct;17(10):1006-14. doi: 10.1002/ejhf.414. Epub 2015 Oct 16. Eur J Heart Fail. 2015. PMID: 26472682 Free article. Clinical Trial.
Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine.
Davarzani N, Sanders-van Wijk S, Maeder MT, Rickenbacher P, Smirnov E, Karel J, Suter T, de Boer RA, Block D, Rolny V, Zaugg C, Pfisterer ME, Peeters R, Brunner-La Rocca HP; TIME-CHF investigators. Davarzani N, et al. EPMA J. 2018 May 13;9(2):161-173. doi: 10.1007/s13167-018-0137-7. eCollection 2018 Jun. EPMA J. 2018. PMID: 29896315 Free PMC article.
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial.
Davarzani N, Hutchins GGA, West NP, Hewitt LC, Nankivell M, Cunningham D, Allum WH, Smyth E, Valeri N, Langley RE, Grabsch HI. Davarzani N, et al. Histopathology. 2018 Jun;72(7):1180-1188. doi: 10.1111/his.13491. Epub 2018 Mar 25. Histopathology. 2018. PMID: 29465751 Free PMC article.
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
Liu DHW, Kim YW, Sefcovicova N, Laye JP, Hewitt LC, Irvine AF, Vromen V, Janssen Y, Davarzani N, Fazzi GE, Jolani S, Melotte V, Magee DR, Kook MC, Kim H, Langer R, Cheong JH, Grabsch HI. Liu DHW, et al. Among authors: davarzani n. Br J Cancer. 2023 Jun;128(12):2318-2325. doi: 10.1038/s41416-023-02257-3. Epub 2023 Apr 7. Br J Cancer. 2023. PMID: 37029200 Free PMC article. Clinical Trial.
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular Subtypes.
Challoner BR, von Loga K, Woolston A, Griffiths B, Sivamanoharan N, Semiannikova M, Newey A, Barber LJ, Mansfield D, Hewitt LC, Saito Y, Davarzani N, Starling N, Melcher A, Grabsch HI, Gerlinger M. Challoner BR, et al. Among authors: davarzani n. J Natl Cancer Inst. 2021 Jan 4;113(1):88-98. doi: 10.1093/jnci/djaa051. J Natl Cancer Inst. 2021. PMID: 32324860 Free PMC article.